STOCK TITAN

Sage Therapeutics to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Sage Therapeutics (Nasdaq: SAGE) announced a live webcast on November 8, 2022, at 8:00 a.m. ET to discuss its third quarter 2022 financial results and recent business updates. The webcast will be accessible via the Investor page on Sage's website, with a replay available for 30 days post-event. Sage Therapeutics is focused on developing innovative solutions for brain health, aiming to deliver impactful medicines to enhance the quality of life.

Positive
  • Scheduled webcast for Q3 2022 financial results may indicate transparency and commitment to investor communication.
Negative
  • None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 8, 2022 at 8:00 a.m. ET to review third quarter 2022 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Investors

Helen Rubinstein

315-382-3979

helen.rubinstein@sagerx.com

Media

Matthew Henson

917-930-7147

matthew.henson@sagerx.com

Source: Sage Therapeutics, Inc.

FAQ

When is Sage Therapeutics' Q3 2022 financial results webcast?

Sage Therapeutics will host its Q3 2022 financial results webcast on November 8, 2022, at 8:00 a.m. ET.

How can I access the Sage Therapeutics webcast?

The webcast can be accessed on the Investor page of Sage Therapeutics' website.

What is the focus of Sage Therapeutics?

Sage Therapeutics is focused on pioneering solutions to improve brain health through innovative medicines.

Sage Therapeutics, Inc

NASDAQ:SAGE

SAGE Rankings

SAGE Latest News

SAGE Stock Data

305.87M
53.88M
11.92%
86.51%
10.48%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
CAMBRIDGE